Global Healthcare Licensing Analytical Report 2019 with Focus on Drug Candidates - ResearchAndMarkets.com

DUBLIN--()--The "Analytical Report for Healthcare Licensing with Focus on Drug Candidates" report has been added to ResearchAndMarkets.com's offering.

In medicines development, the drug candidate is the molecule among several that has been shown to have sufficient target selectivity and potency, and favourable medicine-like properties and justifies further development.

The licensing aspects of the drug candidates are analyzed here. 200+ licensing news with focus on Drug Candidates, during January 1, 2019 to September 30, 2019, are reported and analyzed to provide a snapshot view of the current business trends.

Analytical data coverage:

  • January 1, 2019 to August 31, 2019 licensing deals and negotiations
  • 200+ worldwide Drug Candidates focused healthcare licensing news of companies across North America (50%), Europe (28%), Asia (19%)
  • Small-mid-large cap companies covered - Large Cap (18%)
  • Listed and non-listed companies included
  • 4 healthcare sub-sectors covered - Pharmaceuticals (33%), Biotech (50%), Healthcare Services (13%), Medical Devices (3%)
  • 14 medicine groups studied - Oncology (29%), Neurology (13%), Allergy & Immunology (11%)
  • 8+ variables analyzed

User benefits:

  • Immediate access to current global licensing trends for Drug Candidates
  • Succinct summaries of licensing deals and negotiations held worldwide
  • Quick to-the-point analytical references
  • In-depth updates on wider perspective of Drug Candidates
  • Directions to the emerging business prospects

Key analysis in the report:

  • Leading countries in Drug Candidates focused licensing
  • Most active healthcare sub-sectors in Drug Candidates focused licensing
  • Distribution of Drug Candidates focused licensing deals among market cap groups
  • Comparisons of different medicine groups in Drug Candidates focused licensing
  • Companies currently engaging the most in Drug Candidates focused licensing
  • Dynamics of varied licensing payments arrangements worldwide

Report useful to:

  • Drug Candidates focused healthcare companies seeking licensing opportunities
  • Drug Candidates focused healthcare companies seeking new market base
  • Executives of healthcare companies negotiating licensing for Drug Candidates
  • Investors analyzing varied kinds of transaction options for Drug Candidates focused licensing

Key Topics Covered:

Introduction

Research Design

Chapter 1: Analysis of healthcare inventions with focus on Drug Candidates licensed during the past 8 months

1.1 Number of licensing deals with focus on Drug Candidates

1.2 Countries with most licensing deals with focus on Drug Candidates

1.3 Healthcare sub-sectors with most licensing deals with focus on Drug Candidates

1.4 Market capitalization groups with most licensing deals with focus on Drug Candidates

1.5 Medicine groups with most licensing deals with focus on Drug Candidates

1.6 Leading companies with most licensing deals with focus on Drug Candidates

1.7 Licensing payment arrangements most followed in licensing deals with focus on Drug Candidates

Chapter 2: Key licensing deals with focus on Drug Candidates during the past 8 months - By type of licensing deal

Chapter 3: Global healthcare inventions with focus on Drug Candidates licensed during the past 8 months - By region and company name

Chapter 4: Summary and conclusions

Appendices

Appendix 1 List of companies/institutes covered

a) By region, country and company name

b) By sub-industry, country and company name

c) By market capitalization group, country and company name

d) By medicine group, country and company name

e) By terms of payment, country and company name

Appendix 2 List of non-listed companies covered - By country and company name

Appendix 3 List of not-for-profit institutes covered - By country and institute name

For more information about this report visit https://www.researchandmarkets.com/r/ah9422

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900